Researchers have identified a network of connections linking the brainstem and spinal cord that helps control hand and arm movements, revealing an unexpected layer of the nervous system enabling ...

During the peer-review process the editor and reviewers write an eLife assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) ...

Food was by far the most important factor for their presence, with the spiky mammals appearing in 78% of gardens that supplied hedgehog food and 53% of gardens where bird food was left on the ground.

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis. The ...

Stop us if you’ve heard this one: A hedgehog, a river otter and an iguana walk into a local exotic animal hospital … Whether intentional or otherwise, exotic pets like sharks, macaws and pythons have ...

Treatment with Endeavor Biomedicines’ experimental oral therapy taladegib (ENV-101) improved lung function in people with idiopathic pulmonary fibrosis (IPF) in a Phase 2a clinical trial, newly ...

OKLAHOMA CITY, Oct. 9, 2025 /PRNewswire/ -- Cadenza Bio, Inc. today announced that a collaborative study, "Chloroindazole based Estrogen Receptor β ligands with favorable pharmacokinetics promote ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, ...

A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), ...

The Hippo/yes-associated protein (YAP) signaling is an evolutionarily conserved regulator in organ size control, which plays pivotal roles in cell proliferation, differentiation, apoptosis, and tissue ...

Sophie Lund Rasmussen does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

A phase II trial of perioperative oral itraconazole for the management of low risk basal cell carcinoma. Cumulative incidence of first adverse event at 3, 6 and 12 months. 3 months [95CI] 6 months ...